Search: onr:"swepub:oai:DiVA.org:uu-210574" >
BPIFB1 Is a Lung-Sp...
-
Shum, Anthony K.
(author)
BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease
- Article/chapterEnglish2013
Publisher, publication year, extent ...
-
American Association for the Advancement of Science (AAAS),2013
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-210574
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-210574URI
-
https://doi.org/10.1126/scitranslmed.3006998DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Interstitial lung disease (ILD) is a complex and heterogeneous disorder that is often associated with autoimmune syndromes. Despite the connection between ILD and autoimmunity, it remains unclear whether ILD can develop from an autoimmune response that specifically targets the lung parenchyma. We examined a severe form of autoimmune disease, autoimmune polyglandular syndrome type 1 (APS1), and established a strong link between an autoimmune response to the lung-specific protein BPIFB1 (bactericidal/permeability-increasing fold-containing B1) and clinical ILD. Screening of a large cohort of APS1 patients revealed autoantibodies to BPIFB1 in 9.6% of APS1 subjects overall and in 100% of APS1 subjects with ILD. Further investigation of ILD outside the APS1 disorder revealed BPIFB1 autoantibodies present in 14.6% of patients with connective tissue disease-associated ILD and in 12.0% of patients with idiopathic ILD. The animal model for APS1, Aire(-/-) mice, harbors autoantibodies to a similar lung antigen (BPIFB9); these autoantibodies are a marker for ILD. We found that a defect in thymic tolerance was responsible for the production of BPIFB9 autoantibodies and the development of ILD. We also found that immunoreactivity targeting BPIFB1 independent of a defect in Aire also led to ILD, consistent with our discovery of BPIFB1 autoantibodies in non-APS1 patients. Overall, our results demonstrate that autoimmunity targeting the lung-specific antigen BPIFB1 may contribute to the pathogenesis of ILD in patients with APS1 and in subsets of patients with non-APS1 ILD, demonstrating the role of lung-specific autoimmunity in the genesis of ILD.
Added entries (persons, corporate bodies, meetings, titles ...)
-
Alimohammadi, MohammadUppsala universitet,Autoimmunitet(Swepub:uu)moali133
(author)
-
Tan, Catherine L.
(author)
-
Cheng, Mickie H.
(author)
-
Metzger, Todd C.
(author)
-
Law, Christopher S.
(author)
-
Lwin, Wint
(author)
-
Perheentupa, Jaakko
(author)
-
Bour-Jordan, Helene
(author)
-
Carel, Jean Claude
(author)
-
Husebye, Eystein S.
(author)
-
De Luca, Filippo
(author)
-
Janson, ChristerUppsala universitet,Lungmedicin och allergologi(Swepub:uu)chrisjn
(author)
-
Sargur, Ravishankar
(author)
-
Dubois, Noemie
(author)
-
Kajosaari, Merja
(author)
-
Wolters, Paul J.
(author)
-
Chapman, Harold A.
(author)
-
Kämpe, OlleUppsala universitet,Autoimmunitet(Swepub:uu)ollekamp
(author)
-
Anderson, Mark S.
(author)
-
Uppsala universitetAutoimmunitet
(creator_code:org_t)
Related titles
-
In:Science Translational Medicine: American Association for the Advancement of Science (AAAS)5:206, s. 206ra139-1946-62341946-6242
Internet link
Find in a library
To the university's database
- By the author/editor
-
Shum, Anthony K.
-
Alimohammadi, Mo ...
-
Tan, Catherine L ...
-
Cheng, Mickie H.
-
Metzger, Todd C.
-
Law, Christopher ...
-
show more...
-
Lwin, Wint
-
Perheentupa, Jaa ...
-
Bour-Jordan, Hel ...
-
Carel, Jean Clau ...
-
Husebye, Eystein ...
-
De Luca, Filippo
-
Janson, Christer
-
Sargur, Ravishan ...
-
Dubois, Noemie
-
Kajosaari, Merja
-
Wolters, Paul J.
-
Chapman, Harold ...
-
Kämpe, Olle
-
Anderson, Mark S ...
-
show less...
- Articles in the publication
-
Science Translat ...
- By the university
-
Uppsala University